Additional file 1: of Prospective analysis of circulating metabolites and breast cancer in EPIC

  • Mathilde His (Ophavsperson)
  • Vivian Viallon (Ophavsperson)
  • Laure Dossus (Ophavsperson)
  • Audrey Gicquiau (Ophavsperson)
  • David Achaintre (Ophavsperson)
  • Augustin Scalbert (Ophavsperson)
  • Pietro Ferrari (Ophavsperson)
  • I Romieu (Ophavsperson)
  • N Charlotte Onland-Moret (Bidrager)
  • Elisabete Weiderpass (Ophavsperson)
  • Christina C. Dahm (Aarhus University) (Ophavsperson)
  • Kim Overvad (Ophavsperson)
  • Anja Olsen (Ophavsperson)
  • Anne Tjønneland (Ophavsperson)
  • Agnès Fournier (Ophavsperson)
  • Joseph A. Rothwell (Ophavsperson)
  • Gianluca Severi (Ophavsperson)
  • Tilman Kühn (Ophavsperson)
  • Renée T. Fortner (Ophavsperson)
  • Heiner Boeing (Ophavsperson)
  • Antonia Trichopoulou (Ophavsperson)
  • Anna Karakatsani (Ophavsperson)
  • Georgia Martimianaki (Ophavsperson)
  • G Masala (Ophavsperson)
  • Sabina Sieri (Ophavsperson)
  • Rosario Tumino (Ophavsperson)
  • Paolo Vineis (Ophavsperson)
  • S Panico (Ophavsperson)
  • Carla H van Gils (Bidrager)
  • Therese H Nøst (Ophavsperson)
  • Torkjel M Sandanger (Bidrager)
  • Guri Skeie (Ophavsperson)
  • J Ramón Quirós (Bidrager)
  • Antonio Agudo (Ophavsperson)
  • Maria José Sánchez (Bidrager)
  • Pilar Amiano (Ophavsperson)
  • J M Huerta (Ophavsperson)
  • E Ardanaz (Ophavsperson)
  • Julie A Schmidt (Ophavsperson)
  • Ruth C Travis (Ophavsperson)
  • Elio Riboli (Ophavsperson)
  • Konstantinos K Tsilidis (Ophavsperson)
  • Sofia Christakoudi (Ophavsperson)
  • Marc J Gunter (Ophavsperson)
  • Sabina Rinaldi (Ophavsperson)

Datasæt

Beskrivelse

Supplementary tables describing the completeness of the metabolites measures (Table S1.) and metabolites concentrations by case-control status (Table S2..); Supplementary figures showing age-adjusted correlations between metabolites in control participants (Figure S1.) and adjusted P values for associations between metabolites and different breast cancer subtypes (Figure S2.). Abbreviations: BMI: Body Mass Index; EPIC: European Prospective Investigation into Cancer and nutrition; ER: estrogen receptor; FDR: False Discovery Rate; HER2: Human epidermal growth factor receptor 2; IARC: International Agency for Research on Cancer; MHT: menopause hormone therapy; MS: Mass spectrometry; NMR: nuclear magnetic resonance; OR: odds ratio; PC: phosphatidylcholine; PR: progesterone receptor; SD: standard deviation; WC: waist circumference. (PDF 1041 kb)
Dato for tilgængelighed2019
ForlagFigshare
  • Prospective analysis of circulating metabolites and breast cancer in EPIC

    His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland-Moret, N. C., Weiderpass, E., Dahm, C. C., Overvad, K., Olsen, A., Tjonneland, A., Fournier, A., Rothwell, J. A., Severi, G., Kuehn, T., Fortner, R. T. & Boeing, H. & 25 flere, Trichopoulou, A., Karakatsani, A., Martimianaki, G., Masala, G., Sieri, S., Tumino, R., Vineis, P., Panico, S., van Gils, C. H., Nost, T. H., Sandanger, T. M., Skeie, G., Quiros, J. R., Agudo, A., Sanchez, M.-J., Amiano, P., Maria Huerta, J., Ardanaz, E., Schmidt, J. A., Travis, R. C., Riboli, E., Tsilidis, K. K., Christakoudi, S., Gunter, M. J. & Rinaldi, S., 24 sep. 2019, I: BMC Medicine. 17, 1, 13 s., 178.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    Åben adgang
    Fil
    89 Citationer (Scopus)
    60 Downloads (Pure)

Citationsformater